Company News

AiFChem Awarded Scientist.com's 2025 Supplier Performance Recognition Award

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

XtalPi and Dong-A ST Sign MOU to Advance AI-Driven Drug Discovery for Immunology and Inflammatory Diseases

XtalPi Announces Completion of Acquisition of UK-based Liverpool ChiroChem (LCC) Technology Company

XtalPi Technology Catalyst Synthesis Workstation Successfully Delivered!

New Breakthrough in AI Chemical Synthesis: Automation Data Helps Model Precision